Behavioral and transcriptomic analysis of Trem2-null mice: Not all knockout mice are created equal

Sylvia Kang, Aishe Kurti, Kelsey E. Baker, Chia-Chen Liu, Marco Colonna, Jason D. Ulrich, David M. Holtzman, Guojun D Bu, John D. Fryer

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

It is clear that innate immune system status is altered in numerous neurodegenerative diseases. Human genetic studies have demonstrated that triggering receptor expressed in myeloid cells 2 (TREM2) coding variants have a strong association with Alzheimer's disease (AD) and other neurodegenerative diseases. To more thoroughly understand the impact of TREM2 in vivo, we studied the behavioral and cognitive functions of wild-type (WT) and Trem2-/- (KO) mice during basal conditions and brain function in the context of innate immune stimulation with peripherally administered lipopolysaccharide (LPS). Early markers of neuroinflammation preceded Aif1 and Trem2 upregulation that occurred at later stages (24-48h post-LPS). We performed a transcriptomic study of these cohorts and found numerous transcripts and pathways that were altered in Trem2-/- mice both at baseline and 48h after LPS challenge. Importantly, our transcriptome analysis revealed that our Trem2-/- mouse line (Velocigene allele) results in exaggerated Treml1 upregulation. In contrast, aberrantly high Treml1 expression was absent in the Trem2 knockout line generated by the Colonna lab and the Jackson Labs CRISPR/Cas9 Trem2 knockout line. Notably, removal of the floxed neomycin selection cassette ameliorated aberrant Treml1 expression, validating the artifactual nature of Treml1 expression in the original Trem2-/- Velocigene line. Clearly further studies are needed to decipher whether the Treml1 transcriptional artifact is functionally meaningful, but our data indicate that caution is warranted when interpreting functional studies with this particular line. Additionally, our results indicate that other Velocigene alleles or targeting strategies with strong heterologous promoters need to carefully consider downstream genes.

Original languageEnglish (US)
Pages (from-to)211-223
Number of pages13
JournalHuman Molecular Genetics
Volume27
Issue number2
DOIs
StatePublished - Jan 15 2018

Fingerprint

Knockout Mice
Lipopolysaccharides
Myeloid Cells
Neurodegenerative Diseases
Up-Regulation
Clustered Regularly Interspaced Short Palindromic Repeats
Alleles
Neomycin
Medical Genetics
Gene Expression Profiling
Artifacts
Cognition
Immune System
Alzheimer Disease
Cohort Studies
Brain
Genes

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Behavioral and transcriptomic analysis of Trem2-null mice : Not all knockout mice are created equal. / Kang, Sylvia; Kurti, Aishe; Baker, Kelsey E.; Liu, Chia-Chen; Colonna, Marco; Ulrich, Jason D.; Holtzman, David M.; Bu, Guojun D; Fryer, John D.

In: Human Molecular Genetics, Vol. 27, No. 2, 15.01.2018, p. 211-223.

Research output: Contribution to journalArticle

Kang, Sylvia ; Kurti, Aishe ; Baker, Kelsey E. ; Liu, Chia-Chen ; Colonna, Marco ; Ulrich, Jason D. ; Holtzman, David M. ; Bu, Guojun D ; Fryer, John D. / Behavioral and transcriptomic analysis of Trem2-null mice : Not all knockout mice are created equal. In: Human Molecular Genetics. 2018 ; Vol. 27, No. 2. pp. 211-223.
@article{5ff7c84aa71743cd903f741a032be1a6,
title = "Behavioral and transcriptomic analysis of Trem2-null mice: Not all knockout mice are created equal",
abstract = "It is clear that innate immune system status is altered in numerous neurodegenerative diseases. Human genetic studies have demonstrated that triggering receptor expressed in myeloid cells 2 (TREM2) coding variants have a strong association with Alzheimer's disease (AD) and other neurodegenerative diseases. To more thoroughly understand the impact of TREM2 in vivo, we studied the behavioral and cognitive functions of wild-type (WT) and Trem2-/- (KO) mice during basal conditions and brain function in the context of innate immune stimulation with peripherally administered lipopolysaccharide (LPS). Early markers of neuroinflammation preceded Aif1 and Trem2 upregulation that occurred at later stages (24-48h post-LPS). We performed a transcriptomic study of these cohorts and found numerous transcripts and pathways that were altered in Trem2-/- mice both at baseline and 48h after LPS challenge. Importantly, our transcriptome analysis revealed that our Trem2-/- mouse line (Velocigene allele) results in exaggerated Treml1 upregulation. In contrast, aberrantly high Treml1 expression was absent in the Trem2 knockout line generated by the Colonna lab and the Jackson Labs CRISPR/Cas9 Trem2 knockout line. Notably, removal of the floxed neomycin selection cassette ameliorated aberrant Treml1 expression, validating the artifactual nature of Treml1 expression in the original Trem2-/- Velocigene line. Clearly further studies are needed to decipher whether the Treml1 transcriptional artifact is functionally meaningful, but our data indicate that caution is warranted when interpreting functional studies with this particular line. Additionally, our results indicate that other Velocigene alleles or targeting strategies with strong heterologous promoters need to carefully consider downstream genes.",
author = "Sylvia Kang and Aishe Kurti and Baker, {Kelsey E.} and Chia-Chen Liu and Marco Colonna and Ulrich, {Jason D.} and Holtzman, {David M.} and Bu, {Guojun D} and Fryer, {John D.}",
year = "2018",
month = "1",
day = "15",
doi = "10.1093/hmg/ddx366",
language = "English (US)",
volume = "27",
pages = "211--223",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Behavioral and transcriptomic analysis of Trem2-null mice

T2 - Not all knockout mice are created equal

AU - Kang, Sylvia

AU - Kurti, Aishe

AU - Baker, Kelsey E.

AU - Liu, Chia-Chen

AU - Colonna, Marco

AU - Ulrich, Jason D.

AU - Holtzman, David M.

AU - Bu, Guojun D

AU - Fryer, John D.

PY - 2018/1/15

Y1 - 2018/1/15

N2 - It is clear that innate immune system status is altered in numerous neurodegenerative diseases. Human genetic studies have demonstrated that triggering receptor expressed in myeloid cells 2 (TREM2) coding variants have a strong association with Alzheimer's disease (AD) and other neurodegenerative diseases. To more thoroughly understand the impact of TREM2 in vivo, we studied the behavioral and cognitive functions of wild-type (WT) and Trem2-/- (KO) mice during basal conditions and brain function in the context of innate immune stimulation with peripherally administered lipopolysaccharide (LPS). Early markers of neuroinflammation preceded Aif1 and Trem2 upregulation that occurred at later stages (24-48h post-LPS). We performed a transcriptomic study of these cohorts and found numerous transcripts and pathways that were altered in Trem2-/- mice both at baseline and 48h after LPS challenge. Importantly, our transcriptome analysis revealed that our Trem2-/- mouse line (Velocigene allele) results in exaggerated Treml1 upregulation. In contrast, aberrantly high Treml1 expression was absent in the Trem2 knockout line generated by the Colonna lab and the Jackson Labs CRISPR/Cas9 Trem2 knockout line. Notably, removal of the floxed neomycin selection cassette ameliorated aberrant Treml1 expression, validating the artifactual nature of Treml1 expression in the original Trem2-/- Velocigene line. Clearly further studies are needed to decipher whether the Treml1 transcriptional artifact is functionally meaningful, but our data indicate that caution is warranted when interpreting functional studies with this particular line. Additionally, our results indicate that other Velocigene alleles or targeting strategies with strong heterologous promoters need to carefully consider downstream genes.

AB - It is clear that innate immune system status is altered in numerous neurodegenerative diseases. Human genetic studies have demonstrated that triggering receptor expressed in myeloid cells 2 (TREM2) coding variants have a strong association with Alzheimer's disease (AD) and other neurodegenerative diseases. To more thoroughly understand the impact of TREM2 in vivo, we studied the behavioral and cognitive functions of wild-type (WT) and Trem2-/- (KO) mice during basal conditions and brain function in the context of innate immune stimulation with peripherally administered lipopolysaccharide (LPS). Early markers of neuroinflammation preceded Aif1 and Trem2 upregulation that occurred at later stages (24-48h post-LPS). We performed a transcriptomic study of these cohorts and found numerous transcripts and pathways that were altered in Trem2-/- mice both at baseline and 48h after LPS challenge. Importantly, our transcriptome analysis revealed that our Trem2-/- mouse line (Velocigene allele) results in exaggerated Treml1 upregulation. In contrast, aberrantly high Treml1 expression was absent in the Trem2 knockout line generated by the Colonna lab and the Jackson Labs CRISPR/Cas9 Trem2 knockout line. Notably, removal of the floxed neomycin selection cassette ameliorated aberrant Treml1 expression, validating the artifactual nature of Treml1 expression in the original Trem2-/- Velocigene line. Clearly further studies are needed to decipher whether the Treml1 transcriptional artifact is functionally meaningful, but our data indicate that caution is warranted when interpreting functional studies with this particular line. Additionally, our results indicate that other Velocigene alleles or targeting strategies with strong heterologous promoters need to carefully consider downstream genes.

UR - http://www.scopus.com/inward/record.url?scp=85042352671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042352671&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddx366

DO - 10.1093/hmg/ddx366

M3 - Article

C2 - 29040522

AN - SCOPUS:85042352671

VL - 27

SP - 211

EP - 223

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 2

ER -